GP5 and epilepsy: Specifically, the model demonstrated that the presence of epilepsy pathology was predominantly explained with a reduced relative abundance of a galactose N-glycan structure and a core fucosylated N-glycan structure, as well as an increased relative abundance of a core fucosylated N-glycan structure, a bisected GlcNAc N-glycan structure and a high-mannitose N-glycan structure (GP5).